Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
1841 |
|
| Actual shortage: | 45 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 13 (1%) | |
| Resolved: | 1782 (97%) | |
Discontinuation Reports |
82 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 79 (96%) | |
| Reversed: | 2 (2%) | |
Late reports |
439 (23%) |
|
Overdue reports |
1 (2%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ RISEDRONATE | 35MG | TABLET | Resolved | 2018-10-15 | 2018-12-06 | 64126 |
| SANDOZ RISEDRONATE | 35MG | TABLET | Resolved | 2023-08-07 | 2023-08-30 | 201283 |
| SANDOZ RISEDRONATE | 35MG | TABLET | Resolved | 2024-02-26 | 2024-03-12 | 220555 |
| SANDOZ DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-07-06 | 2020-04-01 | 14879 |
| SANDOZ DEFERASIROX (TYPE J) | 360MG | TABLET | Actual shortage | 2024-04-23 | 2024-05-21 | 225962 |
| ESTRADOT 37.5 | 37.5MCG | PATCH | Resolved | 2020-05-05 | 2020-06-09 | 114104 |
| ESTRADOT 37.5 | 37.5MCG | PATCH | Resolved | 2020-07-16 | 2020-09-11 | 120521 |
| ESTRADOT 37.5 | 37.5MCG | PATCH | Resolved | 2023-09-19 | 2023-11-14 | 204735 |
| ESTRADOT 37.5 | 37.5MCG | PATCH | Resolved | 2024-01-23 | 2024-05-01 | 217044 |
| SANDOZ VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-10-09 | 2018-12-18 | 63514 |
| SANDOZ VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-02-04 | 2019-03-13 | 74734 |
| SANDOZ VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2020-01-22 | 86402 |
| SANDOZ FENTANYL PATCH | 37MCG | PATCH | Resolved | 2020-04-16 | 2020-04-27 | 112407 |
| SANDOZ FENTANYL PATCH | 37MCG | PATCH | Resolved | 2021-09-02 | 2021-09-09 | 145007 |
| SANDOZ FENTANYL PATCH | 37MCG | PATCH | Resolved | 2021-12-20 | 2022-01-12 | 151610 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2017-03-28 | 2017-05-17 | 4586 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2018-05-29 | 2018-08-13 | 50678 |
| SANDOZ RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2019-02-04 | 2019-04-10 | 74710 |
| SANDOZ RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2021-11-15 | 2021-12-20 | 149283 |
| SANDOZ RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2022-02-01 | 2022-03-11 | 154015 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-08-18 | 2021-08-18 | 144303 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |